Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.08 | 14.6739130435 | 7.36 | 8.6455 | 6.81 | 31521 | 7.58836202 | CS |
| 4 | 0.84 | 11.0526315789 | 7.6 | 8.7979 | 6.81 | 33593 | 7.78766096 | CS |
| 12 | -0.88 | -9.44206008584 | 9.32 | 12 | 5.99 | 91450 | 8.52009883 | CS |
| 26 | -1.66 | -16.4356435644 | 10.1 | 15.4914 | 5.99 | 62428 | 9.55441226 | CS |
| 52 | 4.24 | 100.952380952 | 4.2 | 34.46 | 4.2 | 204614 | 17.71254501 | CS |
| 156 | -164.36 | -95.1157407407 | 172.8 | 1711.2 | 3.9501 | 7944656 | 34.94291448 | CS |
| 260 | -680.36 | -98.7746806039 | 688.8 | 1711.2 | 3.9501 | 6883957 | 39.27462386 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
